In-licensing is a priority business focus for Raifarm. We believe that emerging markets can greatly benefit from the introduction of cutting-edge medicines that are capable of dramatically improving patients’ lives.

We partner with drug manufacturers to introduce their products in emerging markets. In return for exclusive rights we register and market new drugs thus creating strong additional sales for a manufacturer. Companies partner with us because of our in-depth knowledge and understanding of these markets, superior operating efficiencies, clear business strategy, and Western ethics and transparency standards.

We are interested in potential partnerships with parties from all over the world. While our current strategy focuses on original and innovative products, we will seriously consider all opportunities for collaboration in this field.